What was old is new again: Using the host response to diagnose infectious disease

Expert Review of Molecular Diagnostics

Volumn 15, Issue 9, 2015, Pages 1143-1158

  Ko, Emily R ^a   Yang, William E ^a   McClain, Micah T ^a,b   Woods, Christopher W ^a,b   Ginsburg, Geoffrey S ^a   Tsalik, Ephraim L ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

communicable diseases; early diagnosis; host pathogen interactions; metabolome; molecular diagnostics; proteome; respiratory tract infection; sepsis; transcriptome; tuberculosis

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD14 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LACTIC ACID; MICRORNA; PROADRENOMEDULLIN; PROCALCITONIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; UROKINASE;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BIOMICS; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; ERYTHROCYTE SEDIMENTATION RATE; FUNGAL DETECTION; FUNGEMIA; GRAM NEGATIVE SEPSIS; GRAM POSITIVE INFECTION; HEALTHCARE ASSOCIATED INFECTION; HORMONE BLOOD LEVEL; HUMAN; IMMUNE RESPONSE; INFECTION; LACTATE BLOOD LEVEL; METABOLOMICS; MICROORGANISM DETECTION; NONHUMAN; PERSONALIZED MEDICINE; POPULATION; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEOMICS; REVIEW; SENSITIVITY AND SPECIFICITY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRANSCRIPTOMICS; TUBERCULOSIS; VIRUS INFECTION; COMMUNICABLE DISEASES; GENOMICS; HOST PATHOGEN INTERACTION; METABOLISM; PROCEDURES;

BIOMARKERS; COMMUNICABLE DISEASES; EARLY DIAGNOSIS; GENOMICS; HOST-PATHOGEN INTERACTIONS; HUMANS; METABOLOMICS; PROTEOMICS;

EID: 84940490759     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.2015.1059278     Document Type: Review

References (178)

1. Cox FE. History of human parasitology. Clin Microbiol Rev 2002;15(4):595-612
2. Bryan CP. The Papyrus Ebers. Appleton; New York, NY: 1931
3. Waugh TR. The blood sedimentation test; its history, technique, nature and clinical application. Can Med Assoc J 1923;13(8): 604-8
4. Tillett WS, Francis T. Serological Reactions in Pneumonia with a Non-Protein Somatic Fraction of Pneumococcus. J Exp Med 1930;52(4):561-71
5. Deirmengian C, Kardos K, Kilmartin P, et al. Diagnosing periprosthetic joint infection: has the era of the biomarker arrived? Clin Orthop Relat Res 2014; 472(11):3254-62
6. Drain PK, Mayeza L, Bartman P, et al. Diagnostic accuracy and clinical role of rapid C-reactive protein testing in HIV-infected individuals with presumed tuberculosis in South Africa. Int J Tuberc Lung Dis 2014;18(1):20-6
7. Shapiro NI, Howell M, Talmor D. A blueprint for a sepsis protocol. Acad Emerg Med 2005;12(4):352-9
8. Trzeciak S, Dellinger RP, Chansky ME, et al. Serum lactate as a predictor of mortality in patients with infection. Intensive care med 2007;33(6):970-7
9. Howell MD, Donnino MW, Talmor D, et al. Performance of severity of illness scoring systems in emergency department patients with infection. Acad Emerg Med 2007;14(8):709-14
10. Mikkelsen ME, Miltiades AN, Gaieski DF, et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 2009;37(5):1670-7
11. Glickman SW, Cairns CB, Otero RM, et al. Disease progression in hemodynamically stable patients presenting to the emergency department with sepsis. Acad Emerg Med 2010;17(4):383-90
12. Cairns CB. Rude unhinging of the machinery of life: metabolic approaches to hemorrhagic shock. Curr Opin Crit Care 2001;7(6):437-43
13. Boulos M, Astiz ME, Barua RS, Osman M. Impaired mitochondrial function induced by serum from septic shock patients is attenuated by inhibition of nitric oxide synthase and poly(ADP-ribose) synthase. Crit Care Med 2003;31(2):353-8
14. Trzeciak S, Dellinger RP, Parrillo JE, et al. Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med 2007;49(1):88-98
15. Shapiro NI, Trzeciak S, Hollander JE, et al. A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med 2009;37(1):96-104
16. Nguyen HB, Rivers EP, Knoblich BP, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 2004;32(8): 1637-42
17. Arnold RC, Shapiro NI, Jones AE, et al. Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock 2009;32(1):35-9
18. Tsalik EL, Woods CW. Sepsis redefined: the search for surrogate markers. Int J Antimicrob Agents 2009;34(Suppl 4): S16-20
19. Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341(8844):515-18
20. Muller B, White JC, Nylen ES, et al. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001;86(1): 396-404
21. Moyer MW. New biomarkers sought for improving sepsis management and care. Nat Med 2012;18(7):999
22. Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994;79(6):1605-8
23. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 2013;13(5): 426-35
24. Suprin E, Camus C, Gacouin A, et al. Procalcitonin: a valuable indicator of infection in a medical ICU? Intensive care med 2000;26(9):1232-8
25. Ugarte H, Silva E, Mercan D, et al. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999;27(3):498-504
26. Balc IC, Sungurtekin H, Gurses E, et al. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care 2003;7(1):85-90
27. Charles PE, Kus E, Aho S, et al. Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report. BMC Infect Dis 2009;9:49
28. Mimoz O, Benoist JF, Edouard AR, et al. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive care med 1998;24(2):185-8
29. Loebe M, Locziewski S, Brunkhorst FM, et al. Procalcitonin in patients undergoing cardiopulmonary bypass in open heart surgery-first results of the Procalcitonin in Heart Surgery study (ProHearts). Intensive Care Med 2000;26(Suppl 2):S193-8
30. Attar BM, Moore CM, George M, et al. Procalcitonin, and cytokines document a dynamic inflammatory state in non-infected cirrhotic patients with ascites. World J Gastroenterol 2014;20(9):2374-82
31. Nagata J, Kobayashi M, Nishikimi N, Komori K. Serum procalcitonin (PCT) as a negative screening test for colonic ischemia after open abdominal aortic surgery. Eur J Vasc Endovasc Surg 2008;35(6):694-7
32. Scire CA, Cavagna L, Perotti C, et al. Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases. Clin Exp Rheumatol 2006;24(2):123-8
33. Nylen ES, Al Arifi A, Becker KL, et al. Effect of classic heatstroke on serum procalcitonin. Crit Care Med 1997;25(8): 1362-5
34. Carsin H, Assicot M, Feger F, et al. Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF alpha and endotoxin levels early after thermal injury. Burns 1997;23(3):218-24
35. Davis BH, Olsen SH, Ahmad E, Bigelow NC. Neutrophil CD64 is an improved indicator of infection or sepsis in emergency department patients. Arch Pathol Lab Med 2006;130(5):654-61
36. Livaditi O, Kotanidou A, Psarra A, et al. Neutrophil CD64 expression and serum IL-8: sensitive early markers of severity and outcome in sepsis. Cytokine 2006;36(5-6): 283-90
37. Lynema S, Marmer D, Hall ES, et al. Neutrophil CD64 as a Diagnostic Marker of Sepsis: Impact on Neonatal Care. Am J Perinatol 2014;32(4):331-6
38. Su L, Feng L, Song Q, et al. Diagnostic value of dynamics serum sCD163, sTREM-1, PCT, and CRP in differentiating sepsis, severity assessment, and prognostic prediction. Mediators Inflamm 2013;2013:969875
39. Adly AA, Ismail EA, Andrawes NG, El-Saadany MA. Circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as diagnostic and prognostic marker in neonatal sepsis. Cytokine 2014;65(2):184-91
40. Arizaga-Ballesteros V, Alcorta-Garcia MR, Lazaro-Martinez LC, et al. Can sTREM-1 predict septic shock & death in late-onset neonatal sepsis? A pilot study. Int J Infect Dis 2015;30:27-32
41. Ravetti CG, Moura AD, Vieira EL, et al. sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock. J Crit Care 2015;30(2):440-e447-440 e413
42. Wittenhagen P, Kronborg G, Weis N, et al. The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality. Clin Micribiol Infect 2004;10(5):409-15
43. Huttunen R, Syrjanen J, Vuento R, et al. Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study. J Intern Med 2011;270(1): 32-40
44. Koch A, Voigt S, Kruschinski C, et al. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Crit Care 2011;15(1):R63
45. Sandquist M, Wong HR. Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment. Expert Rev Clin Immunol 2014;10(10):1349-56
46. Akpinar S, Rollas K, Alagoz A, et al. Performance evaluation of MR-proadrenomedullin and other scoring systems in severe sepsis with pneumonia. J Thorac Disc 2014;6(7):921-9
47. Debiane L, Hachem RY, Al Wohoush I, et al. The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer. Crit Care Med 2014; 42(12):2500-7
48. Oncel MY, Dilmen U, Erdeve O, et al. Proadrenomedullin as a prognostic marker in neonatal sepsis. Pediatr Res 2012;72(5): 507-12
49. Suberviola B, Castellanos-Ortega A, Llorca J, et al. Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia. Swiss Med Wkly 2012;142:w13542
50. Ulla M, Pizzolato E, Lucchiari M, et al. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study. Crit Care 2013;17(4): R168
51. Cakir Madenci O, Yakupoglu S, Benzonana N, et al. Evaluation of soluble CD14 subtype (presepsin) in burn sepsis. Burns 2014;40(4):664-9
52. Masson S, Caironi P, Spanuth E, et al. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial. Crit Care 2014;18(1): R6
53. Selberg O, Hecker H, Martin M, et al. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 2000;28(8):2793-8
54. Wong HR, Lindsell CJ, Pettila V, et al. A multibiomarker-based outcome risk stratification model for adult septic shock. Crit Care Med 2014;42(4):781-9
55. Grover V, Pantelidis P, Soni N, et al. A biomarker panel (Bioscore) incorporating monocytic surface and soluble TREM-1 has high discriminative value for ventilator-associated pneumonia: a prospective observational study. PLoS One 2014;9(10):e109686
56. Freund Y, Delerme S, Goulet H, et al. Serum lactate and procalcitonin measurements in emergency room for the diagnosis and risk-stratification of patients with suspected infection. Biomarkers 2012; 17(7):590-6
57. Liu B, Chen YX, Yin Q, et al. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department. Crit Care 2013;17(5):R244
58. Haran JP, Buglione-Corbett R, Lu S. Cytokine markers as predictors of type of respiratory infection in patients during the influenza season. Am J Emerg Med 2013; 31(5):816-21
59. Hellyer TP, Morris AC, McAuley DF, et al. Diagnostic accuracy of pulmonary host inflammatory mediators in the exclusion of ventilator-acquired pneumonia. Thorax 2015;70(1):41-7
60. Bos LD, de Jong MD, Sterk PJ, Schultz MJ. How integration of global omics-data could help preparing for pandemics-a scent of influenza. Front Genet 2014;5:80
61. Zumla AI, Schito M, Maeurer M. Advancing the portfolio of tuberculosis diagnostics, drugs, biomarkers, and vaccines. Lancet Infect Dis 2014;14(4):267-9
62. Chaudhary N, Kosaraju K, Bhat K, et al. Significance of interleukin-6 (IL-6) and C-reactive protein (CRP) in children and young adults with febrile neutropenia during chemotherapy for cancer: a prospective study. J Pediatr Hematol Oncol 2012;34(8):617-23
63. Chai L, Netea MG, Teerenstra S, et al. Early proinflammatory cytokines and C-reactive protein trends as predictors of outcome in invasive Aspergillosis. J Infect Dis 2010;202(9):1454-62
64. Aittokallio T, Kurki M, Nevalainen O, et al. Computational strategies for analyzing data in gene expression microarray experiments. J Bioinform Compute Biol 2003;1(3):541-86
65. Chen B, Chen M, Paisley J, et al. Bayesian inference of the number of factors in gene-expression analysis: application to human virus challenge studies. BMC Bioinformatics 2010;11:552
66. He Z, Yu W. Stable feature selection for biomarker discovery. Compute Biol Chem 2010;34(4):215-25
67. Chen M, Carlson D, Zaas A, et al. Detection of viruses via statistical gene expression analysis. IEEE Trans Biomed Eng 2011;58(3):468-79
68. Chen M, Zaas A, Woods C, et al. Predicting Viral Infection From High-Dimensional Biomarker Trajectories. J Am Stat Assoc 2011;106(496):1259-79
69. Dunkler D, Sanchez-Cabo F, Heinze G. Statistical analysis principles for Omics data. Methods Mol Biol 2011;719:113-31
70. Carin L, Hero A III, Lucas J, et al. High-Dimensional Longitudinal Genomic Data: An analysis used for monitoring viral infections. IEEE Signal Process Mag 2012; 29(1):108-23
71. Bazot C, Dobigeon N, Tourneret JY, et al. Unsupervised Bayesian linear unmixing of gene expression microarrays. BMC Bioinformatics 2013;14:99
72. Yan Q, Sharma-Kuinkel BK, Deshmukh H, et al. Dusp3 and Psme3 are associated with murine susceptibility to Staphylococcus aureus infection and human sepsis. PLoS Pathog 2014;10(6):e1004149
73. Tsalik EL, Langley RJ, Dinwiddie DL, et al. An integrated transcriptome and expressed variant analysis of sepsis survival and death. Genome Med 2014;6(11):111
74. McNeely TB, Shah NA, Fridman A, et al. Mortality among recipients of the Merck V710 Staphylococcus aureus vaccine after postoperative S. aureus infections: an analysis of possible contributing host factors. Hum Vaccin Immunother 2014; 10(12):3513-16
75. Baginsky S, Hennig L, Zimmermann P, Gruissem W. Gene expression analysis, proteomics, and network discovery. Plant Physiol 2010;152(2):402-10
76. Sutherland A, Thomas M, Brandon RA, et al. Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis. Crit Care 2011;15(3):R149
77. Zaas AK, Aziz H, Lucas J, et al. Blood gene expression signatures predict invasive candidiasis. Sci Transl Med 2010;2(21): 21ra17
78. Ahn SH, Tsalik EL, Cyr DD, et al. Gene expression-based classifiers identify Staphylococcus aureus infection in mice and humans. PloS One 2013;8(1):e48979
79. Kraft BD, Piantadosi CA, Benjamin AM, et al. Development of a novel preclinical model of pneumococcal pneumonia in nonhuman primates. Am J Respir Cell Mol Biol 2014;50(5):995-1004
80. Ramilo O, Allman W, Chung W, et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 2007;109(5):2066-77
81. Zaas AK, Chen M, Varkey J, et al. Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe 2009;6(3):207-17
82. Suarez NM, Bunsow E, Falsey AR, et al. Superiority of Transcriptional Profiling Over Procalcitonin for Distinguishing Bacterial From Viral Lower Respiratory Tract Infections in Hospitalized Adults. J Infect Dis 2015
83. Parnell GP, McLean AS, Booth DR, et al. A distinct influenza infection signature in the blood transcriptome of patients with severe community-acquired pneumonia. Crit Care 2012;16(4):R157
84. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116(2):281-97
85. Stark A, Lin MF, Kheradpour P, et al. Discovery of functional elements in 12 Drosophila genomes using evolutionary signatures. Nature 2007;450(7167):219-32
86. Gilad S, Meiri E, Yogev Y, et al. Serum microRNAs are promising novel biomarkers. PloS One 2008;3(9):e3148
87. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008;105(30): 10513-18
88. Song H, Wang Q, Guo Y, et al. Microarray analysis of microRNA expression in peripheral blood mononuclear cells of critically ill patients with influenza A (H1N1). BMC Infect Dis 2013;13:257
89. Tambyah PA, Sepramaniam S, Mohamed Ali J, et al. microRNAs in circulation are altered in response to influenza A virus infection in humans. PLoS One 2013;8(10):e76811
90. Zhu Z, Qi Y, Ge A, et al. Comprehensive characterization of serum microRNA profile in response to the emerging avian influenza A (H7N9) virus infection in humans. Viruses 2014;6(4):1525-39
91. Paik S. Molecular profiling of breast cancer. Current opinion in obstetrics & gynecology 2006;18(1):59-63
92. Paik S. Methods for gene expression profiling in clinical trials of adjuvant breast cancer therapy. Clin Cancer Res 2006; 12(3 Pt 2):1019s-23s
93. Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004;351(27): 2817-26
94. Paik S, Tang G, Shak S, et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 2006;24(23):3726-34
95. Ademuyiwa FO, Miller A, O'Connor T, et al. The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort. Breast Cancer Res Treat 2011;126(3): 797-802
96. Vargas J, Lima JA, Kraus WE, et al. Use of the Corus(R) CAD gene expression test for assessment of obstructive coronary artery disease likelihood in symptomatic non-diabetic patients. PLos Curr 2013;5
97. Beer NR, Hindson BJ, Wheeler EK, et al. On-chip, real-time, single-copy polymerase chain reaction in picoliter droplets. Anal Chem 2007;79(22):8471-5
98. Beer NR, Wheeler EK, Lee-Houghton L, et al. On-chip single-copy real-time reverse-transcription PCR in isolated picoliter droplets. Anal Chem 2008;80(6): 1854-8
99. Horita N, Miyazawa N, Kojima R, et al. Sensitivity and specificity of the Streptococcus pneumoniae urinary antigen test for unconcentrated urine from adult patients with pneumonia: a meta-analysis. Respirology 2013;18(8):1177-83
100. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002;1(11):845-67
101. Anderson NL, Polanski M, Pieper R, et al. The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol Cell Proteomics 2004;3(4):311-26
102. Ray S, Reddy PJ, Jain R, et al. Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead. Proteomics 2011;11(11): 2139-61
103. Tu C, Rudnick PA, Martinez MY, et al. Depletion of abundant plasma proteins and limitations of plasma proteomics. J Proteome Res 2010;9(10):4982-91
104. Qian WJ, Kaleta DT, Petritis BO, et al. Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy. Mol Cell Proteomics 2008;7(10): 1963-73
105. Keidel EM, Ribitsch D, Lottspeich F. Equalizer technology-Equal rights for disparate beads. Proteomics 2010;10(11): 2089-98
106. Shuford CM, Hawkridge AM, Burnett JC Jr, Muddiman DC. Utilizing spectral counting to quantitatively characterize tandem removal of abundant proteins (TRAP) in human plasma. Anal Chem 2010;82(24):10179-85
107. Cao Z, Yende S, Kellum JA, Robinson RA. Additions to the Human Plasma Proteome via a Tandem MARS Depletion iTRAQ-Based Workflow. Int J Proteomics 2013;2013:654356
108. Hultschig C, Kreutzberger J, Seitz H, et al. Recent advances of protein microarrays. Curr Opin Chem Biol 2006;10(1):4-10
109. McCauley TG, Hamaguchi N, Stanton M. Aptamer-based biosensor arrays for detection and quantification of biological macromolecules. Anal Biochem 2003; 319(2):244-50
110. Oved K, Cohen A, Boico O, et al. A Novel Host-Proteome Signature for Distinguishing between Acute Bacterial and Viral Infections. PLoS One 2015;10(3):e0120012
111. Langley RJ, Tipper JL, Bruse S, et al. Integrative omic analysis of experimental bacteremia identifies a metabolic signature that distinguishes human sepsis from systemic inflammatory response syndromes. Am J Respire Crit Med 2014;190(4):445-55
112. Langley RJ, Tsalik EL, van Velkinburgh JC, et al. An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci Transl Med 2013;5(195): 195ra195
113. Zhang A, Sun H, Yan G, et al. Mass spectrometry-based metabolomics: applications to biomarker and metabolic pathway research. Bio Med Chromtogr 2015;29(3)
114. Lam CW, Law CY, Sze KH, To KK. Quantitative metabolomics of urine for rapid etiological diagnosis of urinary tract infection: evaluation of a microbial-mammalian co-metabolite as a diagnostic biomarker. Clin Chim Acta 2015;438:24-8
115. Carvalho CM, Chang J, Lucas JE, et al. High-Dimensional Sparse Factor Modeling: Applications in Gene Expression Genomics. J Am Stat Assoc 2008;103(484):1438-56
116. Wu Y, Liu Y. Functional robust support vector machines for sparse and irregular longitudinal data. J Comput GraphStat 2013;22(2):379-95
117. Pankla R, Buddhisa S, Berry M, et al. Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis. Genome Biol 2009;10(11):R127
118. Chudova D, Wilde JI, Wang ET, et al. Molecular classification of thyroid nodules using high-dimensionality genomic data. J Clin Entocrinol Metab 2010;95(12): 5296-304
119. Li H, Robinson KA, Anton B, et al. Cost-effectiveness of a novel molecular test for cytologically indeterminate thyroid nodules. J Clin Entocrinol Metab 2011; 96(11):E1719-26
120. Alexander EK, Kennedy GC, Baloch ZW, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med 2012;367(8): 705-15
121. Lytkin NI, McVoy L, Weitkamp JH, et al. Expanding the understanding of biases in development of clinical-grade molecular signatures: a case study in acute respiratory viral infections. PLoS One 2011;6(6): e20662
122. Zaas AK, Garner BH, Tsalik EL, et al. The current epidemiology and clinical decisions surrounding acute respiratory infections. Trends Mol Med 2014;20(10):579-88
123. Tsalik EL, McClain M, Zaas AK. Moving Toward Prime Time: Host Signatures for Diagnosis of Respiratory Infections. J Infect Dis 2015
124. Finfer S, Bellomo R, Lipman J, et al. Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med 2004;30(4): 589-96
125. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from. 1979 through 2000. N Engl J Med 2003;348(16):1546-54
126. Sundararajan V, Macisaac CM, Presneill JJ, et al. Epidemiology of sepsis in Victoria. Australia. Crit Care Med 2005;33(1):71-80
127. Lyle NH, Pena OM, Boyd JH, Hancock RE. Barriers to the effective treatment of sepsis: antimicrobial agents, sepsis definitions, and host-directed therapies. Ann N Y Acad Sci 2014;1323: 101-14
128. Tang BM, McLean AS, Dawes IW, et al. Gene-expression profiling of peripheral blood mononuclear cells in sepsis. Crit Care Med 2009;37(3):882-8
129. Garbino J, Lew DP, Romand JA, et al. Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med 2002;28(12):1708-17
130. Leleu G, Aegerter P, Guidet B, College des Utilisateurs de Base de Donnees en R. Systemic candidiasis in intensive care units: a multicenter, matched-cohort study. J Crit Care 2002;17(3):168-75
131. Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39(3):309-17
132. Marriott DJ, Playford EG, Chen S, et al. Determinants of mortality in non-neutropenic ICU patients with candidaemia. Crit Care 2009;13(4):R115
133. Moran C, Grussemeyer CA, Spalding JR, et al. Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections. Am J Infect Control 2010;38(1): 78-80
134. Alexander BD, Ashley ED, Reller LB, Reed SD. Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures. Diagn Microbiol Infect Dis 2006;54(4):277-82
135. Ling LL, Schneider T, Peoples AJ, et al. A new antibiotic kills pathogens without detectable resistance. Nature 2015; 517(7535):455-9
136. WHO. In: Fukuda K, editor. Antibiotic resistance: global report on surveillance. World Health Organization; 2014. p. 1-232
137. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345(19):1368-77
138. Cantrell R, Young AF, Martin BC. Antibiotic prescribing in ambulatory care settings for adults with colds, upper respiratory tract infections, and bronchitis. Clin Ther 2002;24(1):170-82
139. Shapiro DJ, Hicks LA, Pavia AT, Hersh AL. Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09. J Antimicrob Chemother 2014;69(1):234-40
140. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29(7):1303-10
141. Soni NJ, Samson DJ, Galaydick JL, et al. Procalcitonin-guided antibiotic therapy: a systematic review and meta-analysis. J Hosp Med 2013;8(9):530-40
142. Schuetz P, Muller B, Christ-Crain M, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev 2012;9:CD007498
143. Hu X, Yu J, Crosby SD, Storch GA. Gene expression profiles in febrile children with defined viral and bacterial infection. Proc Natl Acad Sci USA 2013;110(31):12792-7
144. Mejias A, Dimo B, Suarez NM, et al. Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection. PLoS Med 2013;10(11):e1001549
145. Ardura MI, Banchereau R, Mejias A, et al. Enhanced monocyte response and decreased central memory T cells in children with invasive Staphylococcus aureus infections. PLoS One 2009;4(5):e5446
146. Aabdallah DM, Eid NI. Possible neuroprotective effects of lecithin and alpha-tocopherol alone or in combination against ischemia/reperfusion insult in rat brain. J Biochem Mol Toxicol 2004;18(5): 273-8
147. Almasan A, Ashkenazi A. Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev 2003;14(3-4):337-48
148. Liu M, Guo S, Stiles JK. The emerging role of CXCL10 in cancer (Review). Oncol Lett 2011;2(4):583-9
149. Ramirez LA, Arango TA, Thompson E, et al. High IP-10 levels decrease T cell function in HIV-1-infected individuals on ART. J Leukoc Biol 2014;96(6):1055-63
150. Zaas AK, Burke T, Chen M, et al. A host-based RT-PCR gene expression signature to identify acute respiratory viral infection. Sci Transl Med 2013;5(203): 203ra126
151. Woods CW, McClain MT, Chen M, et al. A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2. PLoS One 2013;8(1):e52198
152. Lukaszewski RA, Yates AM, Jackson MC, et al. Presymptomatic prediction of sepsis in intensive care unit patients. Clin Vaccine Immunol 2008;15(7):1089-94
153. McDunn JE, Husain KD, Polpitiya AD, et al. Plasticity of the systemic inflammatory response to acute infection during critical illness: development of the riboleukogram. PLoS ONE 2008;3(2):e1564
154. WHO. Global tuberculosis control. World Health Organization, Geneva, Switzerland; 2011
155. Maynard-Smith L, Larke N, Peters JA, Lawn SD. Diagnostic accuracy of the Xpert MTB/RIF assay for extrapulmonary and pulmonary tuberculosis when testing non-respiratory samples: a systematic review. BMC Infect Dis 2014;14:709
156. McNerney R, Cunningham J, Hepple P, Zumla A. New tuberculosis diagnostics and rollout. Int J Infect Dis 2015;32:81-6
157. Berry MP, Graham CM, McNab FW, et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010;466(7309):973-7
158. Dupuy A, Simon RM. Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. J Natl Cancer Inst 2007;99(2):147-57
159. Koth LL, Solberg OD, Peng JC, et al. Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis. Am J Respire Crit Care Med 2011;184(10):1153-63
160. Maertzdorf J, Weiner J III, Mollenkopf HJ, et al. Common patterns and disease-related signatures in tuberculosis and sarcoidosis. pROC Natl Acad Sci U S A 2012;109(20): 7853-8
161. Koh GC, Schreiber MF, Bautista R, et al. Host responses to melioidosis and tuberculosis are both dominated by interferon-mediated signaling. PLoS ONE 2013;8(1):e54961
162. Berry MP, Blankley S, Graham CM, et al. Systems approaches to studying the immune response in tuberculosis. Curr Opin Immunol 2013;25(5):579-87
163. Cliff JM, Lee JS, Constantinou N, et al. Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. J Infect Dis 2013;207(1):18-29
164. Cliff JM, Kaufmann SH, McShane H, et al. The human immune response to tuberculosis and its treatment: a view from the blood. Immunol Rev 2015;264(1): 88-102
165. Horne DJ, Royce SE, Gooze L, et al. Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis. Lancet Infect Dis 2010;10(6):387-94
166. Nandakumar M, Prosser GA, de Carvalho LP, Rhee K. Metabolomics of Mycobacterium tuberculosis. Methods Mol Biol 2015;1285:105-15
167. Cui T, He ZG. Improved understanding of pathogenesis from protein interactions in Mycobacterium tuberculosis. Expert Rev Proteomics 2014;11(6):745-55
168. Swanepoel CC, Loots du T. The use of functional genomics in conjunction with metabolomics for Mycobacterium tuberculosis research. Dis Markers 2014;2014:124218
169. Sandhu G, Battaglia F, Ely BK, et al. Discriminating active from latent tuberculosis in patients presenting to community clinics. PLoS One 2012;7(5): e38080
170. Agranoff D, Fernandez-Reyes D, Papadopoulos MC, et al. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 2006;368(9540):1012-21
171. De Groote MA, Nahid P, Jarlsberg L, et al. Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment. PLoS One 2013;8(4):e61002
172. Nahid P, Bliven-Sizemore E, Jarlsberg LG, et al. Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis. Tuberculosis 2014; 94(3):187-96
173. Weiner J III, Parida SK, Maertzdorf J, et al. Biomarkers of inflammation, immunosuppression and stress with active disease are revealed by metabolomic profiling of tuberculosis patients. PLoS One 2012;7(7):e40221
174. Suzuki Y, Suda T, Asada K, et al. Serum indoleamine 2,3-dioxygenase activity predicts prognosis of pulmonary tuberculosis. Clin Vaccine Immunol 2012; 19(3):436-42
175. Molins CR, Ashton LV, Wormser GP, et al. Development of a Metabolic Biosignature for Detection of Early Lyme Disease. Clin Infect Dis 2015;60(12): 1767-75
176. Salinas JL, Kissinger JC, Jones DP, Galinski MR. Metabolomics in the fight against malaria. Mem Inst Oswaldo Cruz 2014;109(5):589-97
177. Fink J, Gu F, Ling L, et al. Host gene expression profiling of dengue virus infection in cell lines and patients. PLoS Negl Trop Dis 2007;1(2):e86
178. Simmons CP, Popper S, Dolocek C, et al. Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. J Infect Dis 2007;195(8):1097-107